1998
DOI: 10.1152/jn.1998.79.2.1127
|View full text |Cite
|
Sign up to set email alerts
|

Protein Kinase C Is Required for Long-Lasting Synaptic Enhancement by the Neuropeptide DRNFLRFamide in Crayfish

Abstract: The FMRFamide-related neuropeptide AspArgAsnPheLeuArgPhe-NH2 (DRNFLRFamide, DF2) induces a long-lasting enhancement of synaptic transmission at neuromuscular junctions on the crayfish deep abdominal extensor muscles. Here we investigated the function of protein kinase C (PKC) in this effect because PKC has been implied in the control of long-term synaptic modulation in other systems. The general kinase antagonist staurosporine reduced both the initial increase in excitatory postsynaptic potential (EPSP) amplit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

1999
1999
2007
2007

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 25 publications
0
12
0
Order By: Relevance
“…FMRFamides enhance transmitter release at crustacean neuromuscular junctions (Kravitz et al, 1980;Mercier et al, 1990;Skerrett et al, 1995;Worden et al, 1995;Jorge-Rivera and Marder, 1996;Friedrich et al, 1998). Our finding that one of the FMRFamides, DF 2 , is effective in modulating release in the fast but not in the slow neuron innervating the same muscle, is new, and makes generalized statements on the role of modulators precarious.…”
Section: Peptidergic Modulation Of Transmitter Release Is Axon Type-smentioning
confidence: 80%
See 1 more Smart Citation
“…FMRFamides enhance transmitter release at crustacean neuromuscular junctions (Kravitz et al, 1980;Mercier et al, 1990;Skerrett et al, 1995;Worden et al, 1995;Jorge-Rivera and Marder, 1996;Friedrich et al, 1998). Our finding that one of the FMRFamides, DF 2 , is effective in modulating release in the fast but not in the slow neuron innervating the same muscle, is new, and makes generalized statements on the role of modulators precarious.…”
Section: Peptidergic Modulation Of Transmitter Release Is Axon Type-smentioning
confidence: 80%
“…The effect of Ni 2ϩ was largely reversible after 20 min of washing with saline. 15.0 Ϯ 6.4 (n ϭ 8) (n ϭ 7) (n ϭ 6) (n ϭ 8) (n ϭ 11) (n ϭ 5) I (nA) (%) 73.5 Ϯ 4.9 2.3 Ϯ 1.5 35.0 Ϯ 3.9 77.8 Ϯ 6.1 20.6 Ϯ 4.4 13.0 Ϯ 3.8 (n ϭ 10) (n ϭ 7) (n ϭ 6) (n ϭ 11) (n ϭ 10) (n ϭ 6) The modulation of transmitter release by the peptide DF 2 involves -conotoxin-sensitive Ca 2؉ channels As many as 12 LRFamide-like peptides have been identified in crustaceans (Weimann et al, 1993;Sithigorngul et al, 1998Sithigorngul et al, , 2001Mercier et al, 2001), of which four have been shown to modulate transmitter release from neuromuscular endings in crayfish and lobster (Kravitz et al, 1980;Mercier et al, 1990;Skerrett et al, 1995;Worden et al, 1995;Jorge-Rivera and Marder, 1996;Friedrich et al, 1998). Among them is DRNFLRFamide, also referred to as DF 2 , which enhances junction potential amplitudes by increasing the number of transmitter quanta released (Skerrett et al, 1995).…”
Section: Resultsmentioning
confidence: 99%
“…Control recordings indicate that this concentration of DMSO does not alter LFD (data not shown). Drug concentration was chosen empirically based on dose-effect trials and on previous published concentrations used in crayfish [Rp-cAMPS, rapamycin (Beaumont et al, 2001), staurosporine, GF, PMA (Friedrich et al, 1998), OA (Swain et al, 1991;Lin and Fu, 2005), Sp-cAMPS, FK-506 (J. E. Swain and M. P. Charlton, unpublished observation)] or in other invertebrates such as Aplysia (FK-506) (Sharma et al, 2003), Mytilus (calcineurin autoinhibitory peptide) (Yamada et al, 2004), and Drosophila (FK-506) (Kuromi et al, 1997).…”
Section: Methodsmentioning
confidence: 99%
“…Inhibition of protein kinase A or protein kinase C accelerates LFD cAMP-dependent protein kinases A (PKA) and protein kinase C (PKC) were shown to be involved in LTF at crayfish neuromuscular junction (Atwood et al, 1989;Dixon and Atwood, 1989a) and in neuropeptide-induced potentiation (Friedrich et al, 1998). To examine the role of PKA, we applied the inhibitor Rp-cAMPS (300 M), which binds to the regulatory subunit of PKA (Dostmann et al, 1990) 10 min before 0.2 Hz stimulation.…”
Section: Kinase Inhibitor Accelerates Phase II Of Lfdmentioning
confidence: 99%
“…88) It increases the amplitude of excitatory junction potentials (EJPs) in deep extensor muscles (DEMs) involving a presynaptic mechanism requiring calcium/calmodulin-dependent protein kinase, protein kinase C and cyclic nucleotide dependent protein kinases. [86][87][88][89] The synaptic modulation was shown to dependent on temperature and extracellular calcium. 91,92) DRNFLRFamide also induces contraction of superficial abdominal extensor muscles 93) and enhances hindgut contractions.…”
Section: Fmrfamides and Fmrfamide-related Peptides (Farps)mentioning
confidence: 99%